Ellen Strahlman
Director/Board Member presso ALTRIA GROUP, INC.
Patrimonio netto: 704 545 $ in data 31/03/2024
Profilo
Ellen R.
Strahlman is currently an Independent Director at Altria Group, Inc. She is also a Director at Losonoco Ltd.
and an Independent Director at Eyenovia, Inc. Previously, she served as a Non-Executive Director at Syncona Ltd.
from 2016 to 2020.
She was also a Director at Syncona Partners LLP.
Prior to that, she held the position of Chief Medical Officer & Global Head-Research at Bausch & Lomb, Inc. She was the Chief Medical Officer, EVP-Research & Development at Becton, Dickinson & Co. from 2013 to 2017.
She has also worked as a Principal at Merck & Co., Inc., Vice President-Worldwide Business Development at Pfizer Inc., and Principal at Novartis Corp.
From 2008 to 2012, she served as the Chief Medical Officer & Senior Vice President at GSK Plc.
Dr. Strahlman completed her undergraduate studies at Harvard University.
She obtained a graduate degree from Johns Hopkins Bloomberg School of Public Health in 1989.
She also holds a doctorate degree from The Johns Hopkins University School of Medicine.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
ALTRIA GROUP, INC.
0.00% | 29/03/2024 | 14 454 ( 0.00% ) | 630 483 $ | 31/03/2024 |
EYENOVIA, INC.
0.16% | 29/09/2023 | 75 113 ( 0.16% ) | 74 061 $ | 31/03/2024 |
Posizioni attive di Ellen Strahlman
| Società | Posizione | Inizio |
|---|---|---|
| ALTRIA GROUP, INC. | Director/Board Member | 02/11/2020 |
| EYENOVIA, INC. | Director/Board Member | 01/07/2022 |
Losonoco Ltd.
 Losonoco Ltd. Wholesale DistributorsDistribution Services Losonoco Ltd. provides commercial and agricultural waste recycling services. The company builds and operates refineries that re-cycle agricultural, municipal and commercial waste streams into Fuel Ethanol. It helps in improving energy security, reduction of greenhouse gases and diversion of biodegradable waste from landfills. Losonoco is located in London, UK | Director/Board Member | - |
Precedenti posizioni note di Ellen Strahlman
| Società | Posizione | Fine |
|---|---|---|
| SYNCONA LIMITED | Director/Board Member | 02/11/2020 |
| BECTON, DICKINSON AND COMPANY | Chief Tech/Sci/R&D Officer | 31/12/2017 |
| GSK PLC | Chief Tech/Sci/R&D Officer | 01/03/2012 |
Syncona Partners LLP
 Syncona Partners LLP Investment ManagersFinance Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom. | Director/Board Member | - |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Formazione di Ellen Strahlman
| Harvard University | Undergraduate Degree |
| Johns Hopkins Bloomberg School of Public Health | Graduate Degree |
| The Johns Hopkins University School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 6 |
|---|---|
| BECTON, DICKINSON AND COMPANY | Health Technology |
| MERCK & CO., INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| ALTRIA GROUP, INC. | Consumer Non-Durables |
| GSK PLC | Health Technology |
| EYENOVIA, INC. | Health Technology |
| Aziende private | 5 |
|---|---|
Bausch & Lomb, Inc.
 Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Health Technology |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
Losonoco Ltd.
Losonoco Ltd. Wholesale DistributorsDistribution Services Losonoco Ltd. provides commercial and agricultural waste recycling services. The company builds and operates refineries that re-cycle agricultural, municipal and commercial waste streams into Fuel Ethanol. It helps in improving energy security, reduction of greenhouse gases and diversion of biodegradable waste from landfills. Losonoco is located in London, UK | Distribution Services |
Syncona Ltd.
 Syncona Ltd. Investment Trusts/Mutual FundsMiscellaneous Syncona Ltd. is a closed-end investment fund. It engages in delivering returns from investments in long and alternative investment funds across multiple asset classes and targets. The company was founded on August 14, 2012, and is headquartered in St. Peter Port, the United Kingdom. | Miscellaneous |
Syncona Partners LLP
Syncona Partners LLP Investment ManagersFinance Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom. | Finance |
- Borsa valori
- Insiders
- Ellen Strahlman
